ROLL FORWARD FOR THE UK WIDE MAXIMUM PRICE SCHEME FOR GENERIC MEDICINES IN NHS PRIMARY CARE

The maximum price scheme for generic medicines - those without a brand name - will carry on unchanged, said Health Minister, Lord Philip Hunt, today.

The move follows the recent consultation with generic manufacturers, wholesalers and community pharmacies earlier this year.

Lord Hunt said:

"The scheme was introduced in August 2000 as a result of price increases in the generics market that started in 1999.  It was rolled forward in October 2001. 

"The scheme has restored stability in the generics market and the NHS has saved some £330 million annually as a result.  Continuing the scheme will ensure that stability continues and that expenditure savings are maintained.

"We are making good progress on discussing and developing options for longer-term arrangements for the supply and reimbursement of generic medicines to the NHS with interested parties.  We aim to develop new arrangements that will stand the test of time."

NOTES FOR EDITORS

1.         In 2001 the share of prescription items written generically was 74%

2.         The written ministerial statement announcing the roll forward of the maximum price scheme is available on the internet at www.doh.gov.uk/generics

[ENDS]